CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in CNS Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +4 vs. Q2 2024
- Shares held
- 576.2K
- +432.1K (+299.7%) vs. Q2 2024
- Total value
- $75.3K
- −$152.5K (−67.0%) vs. Q2 2024
- New holders
- 7
- 3 more added
- Sold out
- 3
- 0 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNSP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 11 | $1.34M |
| Q1 2026 | 12 | $348.7K |
| Q4 2025 | 10 | $652.4K |
| Q3 2025 | 8 | $221.5K |
| Q2 2025 | 11 | $421.8K |
| Q1 2025 | 7 | $55.2K |
| Q4 2024 | 21 | $297.3K |
| Q3 2024 | 14 | $75.3K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 19 | $351.0K |
| Q4 2023 | 16 | $425.3K |
| Q3 2023 | 12 | $131.7K |
| Q2 2023 | 12 | $234.4K |
| Q1 2023 | 13 | $190.5K |
| Q4 2022 | 10 | $335.0K |
| Q3 2022 | 21 | $232.0K |
| Q2 2022 | 23 | $343.5K |
| Q1 2022 | 20 | $589.0K |
| Q4 2021 | 24 | $828.0K |
| Q3 2021 | 20 | $1.44M |
| Q2 2021 | 20 | $2.64M |
| Q1 2021 | 19 | $3.04M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding CNS Pharmaceuticals, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 203,180 | $26.5K | 0.00% | +203,180 | New |
| UBS Group AG | 181,866 | $23.8K | 0.00% | +179,237+6,817.7% | Added |
| Virtu Financial LLC | 122,876 | $16.0K | 0.00% | +122,876 | New |
| Goldman Sachs Group Inc | 28,197 | $3.68K | 0.00% | +28,197 | New |
| Jane Street Group, LLC | 23,160 | $3.02K | 0.00% | +23,160 | New |
| Tower Research Capital LLC (TRC) | 16,298 | $2.13K | 0.00% | +16,183+14,072.2% | Added |
| Aspire Private Capital, LLC | 400 | $52 | 0.00% | +400 | New |
| Bank of America Corp | 234 | $30 | 0.00% | +233+23,300.0% | Added |
| Wells Fargo & Company | 4 | $1 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 2 | $0 | 0.00% | +2 | New |
| Northwestern Mutual Wealth Management Co | 1 | $0 | 0.00% | +1 | New |
| Anson Funds Management LP | 0 | $0 | 0.00% | −141,398−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |